Literature DB >> 15317712

Colour vision testing as an aid to diagnosis and management of age related maculopathy.

G B Arden1, J E Wolf.   

Abstract

AIM: To provide a simple test that detects the onset of age related maculopathy (ARM), and can be used to monitor its severity.
METHODS: Colour contrast sensitivity was measured using computer graphics techniques. Colour thresholds were measured along tritan and protan colour confusion axes in the presence of dynamic luminance noise. Thresholds were determined separately for two sizes of optotypes (6.5 degrees and 1.5 degrees). Natural pupils were used. Normal values for the test have been established.
RESULTS: In all patients with unilateral age related macular degeneration, the smaller optotype was invisible in that eye and in almost all, the larger optotype could not be seen. In the symptomless fellow eyes (with ARM) the larger optotype thresholds were raised. The degree of loss was larger for tritan. For the smaller optotype, protan thresholds were elevated in the majority of patients. Tritan losses were greater and disproportionate to the loss seen with the larger optotype. Every person including those with minimal fundal changes had tritan test results for 1.5 degree optotypes >2 SD above the normal mean. Tritan thresholds varied with the severity of the ARM.
CONCLUSIONS: The test is sensitive, simple and quick to administer, and easy for patients. Therefore, it should be useful in detecting and monitoring elderly people with age related changes in their fundi before irreversible loss of vision has occurred.

Entities:  

Mesh:

Year:  2004        PMID: 15317712      PMCID: PMC1772298          DOI: 10.1136/bjo.2003.033480

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  50 in total

1.  Electrophysiological abnormalities in age-related macular degeneration.

Authors:  P Walter; R A Widder; C Lüke; P Königsfeld; R Brunner
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1999-12       Impact factor: 3.117

2.  Psychophysical evidence for rod vulnerability in age-related macular degeneration.

Authors:  C Owsley; G R Jackson; A V Cideciyan; Y Huang; S L Fine; A C Ho; M G Maguire; V Lolley; S G Jacobson
Journal:  Invest Ophthalmol Vis Sci       Date:  2000-01       Impact factor: 4.799

3.  The multifocal electroretinogram in age-related maculopathies.

Authors:  S Huang; D Wu; F Jiang; J Ma; L Wu; J Liang; G Luo
Journal:  Doc Ophthalmol       Date:  2000-09       Impact factor: 2.379

4.  Variation of chromatic sensitivity across the life span.

Authors:  K Knoblauch; F Vital-Durand; J L Barbur
Journal:  Vision Res       Date:  2001-01       Impact factor: 1.886

5.  The human electro-oculogram: interaction of light and alcohol.

Authors:  G B Arden; J E Wolf
Journal:  Invest Ophthalmol Vis Sci       Date:  2000-08       Impact factor: 4.799

6.  Relation between macular morphology and visual function in patients with choroidal neovascularisation of age related macular degeneration.

Authors:  N Doris; P M Hart; U Chakravarthy; J McCleland; M Stevenson; C Hudson; J Jackson
Journal:  Br J Ophthalmol       Date:  2001-02       Impact factor: 4.638

7.  Focal electroretinograms and fundus appearance in nonexudative age-related macular degeneration. Quantitative relationship between retinal morphology and function.

Authors:  B Falsini; S Serrao; A Fadda; G Iarossi; G Porrello; F Cocco; E Merendino
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1999-03       Impact factor: 3.117

8.  Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials--TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group.

Authors: 
Journal:  Arch Ophthalmol       Date:  1999-10

9.  Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials-tap report 2.

Authors:  N M Bressler
Journal:  Arch Ophthalmol       Date:  2001-02

10.  Prophylactic laser treatment in early age related maculopathy reduced the incidence of exudative complications.

Authors:  C Frennesson; S E Nilsson
Journal:  Br J Ophthalmol       Date:  1998-10       Impact factor: 4.638

View more
  16 in total

1.  New iPAD-based test for the detection of color vision deficiencies.

Authors:  Dolores de Fez; María José Luque; Lucía Matea; David P Piñero; Vicente J Camps
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-10-06       Impact factor: 3.117

2.  Blue-yellow dyschromatopsia in toluene-exposed workers.

Authors:  Axel Muttray; Volkmar Wolters; Dirk-Matthias Rose
Journal:  Int Arch Occup Environ Health       Date:  2019-01-25       Impact factor: 3.015

Review 3.  Spare the rod and spoil the eye.

Authors:  G B Arden; R L Sidman; W Arap; R O Schlingemann
Journal:  Br J Ophthalmol       Date:  2005-06       Impact factor: 4.638

4.  Early age-related macular degeneration impairs tolerance to stimulus degradation.

Authors:  Lei Liu; Janis White
Journal:  Optom Vis Sci       Date:  2010-08       Impact factor: 1.973

5.  Color vision and neuroretinal function in diabetes.

Authors:  B E Wolff; M A Bearse; M E Schneck; K Dhamdhere; W W Harrison; S Barez; A J Adams
Journal:  Doc Ophthalmol       Date:  2014-12-17       Impact factor: 2.379

6.  Safety monitoring in bevacizumab (Avastin) treatment: retinal function assessed by psychophysical (visual fields, colour vision) and electrophysiological (ERG/EOG) tests in two subgroups of patients.

Authors:  Focke Ziemssen; Matthias Lüke; Andre Messias; Julia Beutel; Olcay Tatar; Eberhart Zrenner; Karl U Bartz-Schmidt
Journal:  Int Ophthalmol       Date:  2007-07-20       Impact factor: 2.031

7.  A randomized placebo-controlled trial of idebenone in Leber's hereditary optic neuropathy.

Authors:  Thomas Klopstock; Patrick Yu-Wai-Man; Konstantinos Dimitriadis; Jacinthe Rouleau; Suzette Heck; Maura Bailie; Alaa Atawan; Sandip Chattopadhyay; Marion Schubert; Aylin Garip; Marcus Kernt; Diana Petraki; Christian Rummey; Mika Leinonen; Günther Metz; Philip G Griffiths; Thomas Meier; Patrick F Chinnery
Journal:  Brain       Date:  2011-07-25       Impact factor: 13.501

8.  Comparison of colour contrast sensitivity in eyes at high risk of neovascular age-related macular degeneration with and without subsequent choroidal neovascular membrane development.

Authors:  Antonio Calcagni; Olivia Howells; Hannah Bartlett; Alastair K O Denniston; Jonathan M Gibson; Christopher R Hogg; Timothy D Matthews; Frank Eperjesi
Journal:  Eye (Lond)       Date:  2022-01-20       Impact factor: 4.456

9.  Simple Vision Function Tests that Distinguish Eyes with Early to Intermediate Age-related Macular Degeneration.

Authors:  Lori A Lott; Marilyn E Schneck; Gunilla Haegerstrom-Portnoy; Susan Hewlett; Natalie Stepien-Bernabe; Bonnie M Gauer; Ali Zaidi; Arthur D Fu; John A Brabyn
Journal:  Ophthalmic Epidemiol       Date:  2020-08-12       Impact factor: 1.648

10.  Effects of idebenone on color vision in patients with leber hereditary optic neuropathy.

Authors:  Guenther Rudolph; Konstantinos Dimitriadis; Boriana Büchner; Suzette Heck; Jasmina Al-Tamami; Florian Seidensticker; Christian Rummey; Mika Leinonen; Thomas Meier; Thomas Klopstock
Journal:  J Neuroophthalmol       Date:  2013-03       Impact factor: 3.042

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.